A Study of JNJ-55308942 in the Treatment of Bipolar Depression

Clinical trial NCT05328297 · COMPLETED

Trial details

NCT number: NCT05328297
Sponsor: Janssen Pharmaceutica N.V., Belgium
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2022-06-03
Primary completion: 2024-05-17
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.